Schott Kaisha expands its vial production capacity for Covid-19 vaccine

New investment of Rs 105 crore to increase vial production by 3 billion

Schott Kaisha
Schott Kaisha stall at CPhI India 2019

Schott Kaisha has announced an immediate investment of Rs 105 crore ( approximately EUR 12 million) into its existing facilities to increase its vial production by 300 million pieces. The decision comes at a time when drug manufacturers around the world are undergoing Covid-19 vaccine trials. Such complex medications are stored in Type 1 glass vials produced at Schott Kaisha plants in Gujarat and Daman.

The Indo- German venture with the international technology group, Schott AG, plans to complete this production ramp-up within a record time of 12 months. A long-term investment plan and consistent infrastructure growth over the years has helped the company expand its production capabilities quickly. Over the last three years, it had invested approximately Rs 434 crore and set up two new plants in Umarsadi, Gujarat, and Baddi, Himachal Pradesh. With the recently opened facility in Umarsadi, Schott Kaisha was already manufacturing over 3 billion pieces of ampoules, vials, syringes, and cartridges annually. The company is providing vaccine vials to all the key vaccine developers in the country and manufacturers abroad.

Rishad Dadachanji, director, Schott Kaisha, said, “Pharma companies all around the world are working relentlessly to find an effective vaccine for Covid-19. As a front-runner in the pharma packaging segment, we are committed to support the vaccine developers with the best packaging solutions. We are closely working with all our clients to supply them with vials and syringes for their vaccine trials and are continuously assessing their requirements to stay ahead of the curve.”

With the looming demand surge for vaccine vials, the pharma industry relies on quality products for storing their complex drug formulations with minimal threat of contamination. Schott Kaisha has been a pioneer in the Indian market to provide customizable solutions to leading pharmaceutical players worldwide. It has always given preference to a ‘quality by design’ approach, benchmark manufacturing, and quality control processes using breakthrough inspection technology, combined with best-in-class components.

The company was established in 1990 as a premium manufacturer of pharmaceutical containers made of neutral glass in India under the name Kaisha Manufacturers. In 2008, it started cooperation with the international technology group Schott. The Indo-German joint venture is a leading supplier for the pharmaceutical industry offering a “one stop shop” solution for the entire range of small volume tubular glass parenteral packaging, including ampoules, vials cartridges, and sterile prefillable glass syringes.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now


Please enter your comment!
Please enter your name here